Skip to main content Skip to footer
American Family Children's Hospital
SHARE TEXT
 


Print Friendly Page

Protocol No. EA5161

Principal Investigator Leal, Ticiana

Phase II

Age Group Adult

Scope National

Sponsor Type National

Title Randomized Phase II Clinical Trial of Cisplatin/Carboplatin and Etoposide (CE) alone or in Combination with Nivolumab as Frontline Therapy for Extensive Stage Small Cell Lung Cancer (ED-SCLC)

Applicable Disease Sites Lung

Drugs Involved BMS-936558 (Nivolumab); Nivolumab; Opdivo (Nivolumab); carboplatin; cbdca (carboplatin); cis-diamminedichloroplatinum (cisplatin); cisplatin; etoposide; paraplatin (carboplatin); platinol (cisplatin); platinum (cisplatin); vepesid (etoposide); vp-16 (etoposide)

Status Open (affiliates only)